Alembic Pharma's Vadodara unit passes FDA test with VAI remark
Voluntary action indicated (VAI) is suggested when violations are found, but the problems do not justify further regulatory action. Shares of Alembic Pharmaceuticals Ltd ended at ₹809, down by ₹17.20, or 2.08%, on the BSE.

What's Your Reaction?






